Review Article
miR-30 Family: A Promising Regulator in Development and Disease
Table 2
The targets of miR-30 family members in tissue and organ development and clinical diseases.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Notes. BMP2: bone morphogenetic protein-2; Smad1: SMAD family member 1; Runx2: runt-related transcription factor 2; Skp2: S-phase kinase related protein 2; Ubej1: ubiquitin-conjugating enzyme E2, J1; UCP1: uncoupling protein 1; Cidea: cell death-inducing DFFA-like effector a; DLL4: δ-like ligand 4; ATG5: autophagy related protein 5; PI3K: phosphoinositide 3-kinase; FOXL2: forkhead box protein L2; BCLA1: B-cell lymphoma 2 related protein A1; IER3: immediate early response 3; IL-10: interleukin-10; ACE2: angiotensin-converting enzyme 2; ATG6: autophagy related protein 6; TGF-β: transforming growth factor-β; ERG: EST-related genes; WISP1: WNT1-induced signaling pathway protein 1; MyD88: bone marrow differentiation factor 88; REDD1: DNA damage inducible transcript 4; NF-KB: nuclear factor kappa B; Mcl-1: BCL2 family apoptosis regulator. |